Bioprocessing White Papers

  1. Quality By Design: Understanding And Securing Virus Clearance 4/22/2026

    Data-driven virus clearance improves risk assessment, process insight, and study design. Learn how Quality by Design cuts late-stage risk while strengthening regulatory confidence and viral safety.

  2. Cell Based Potency Assays: De-Risk Your Path With An Experienced CDMO 4/21/2026

    Thorough characterization is key to unlocking the potential of antibody-based therapeutics. Leveraging a CDMO's extensive capabilities and expertise can allow you to navigate the biopharmaceutical development landscape.

  3. De-Risk Nucleic Acid Therapeutics Through Strategic Outsourcing 4/20/2026

    Bringing a nucleic acid therapy to market requires specialized formulation and development knowledge. Innovators need rigorous analytical and formulation strategies to achieve stability and quality.

  4. Life Cycle Assessment Of Extended Use Strategies For Single-Use Assemblies 4/17/2026

    Examine how extending the use of single‑use assemblies can significantly reduce emissions, resource consumption, and waste in bioprocessing, offering a data‑backed path toward sustainability.

  5. ADC Development Grows More Complex — SPR Insights Bring Clarity 4/14/2026

    Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

  6. The Open Standard For Plug-And-Produce 4/14/2026

    Take a look at how standardized, modular production simplifies line integration, reduces engineering effort, and enables faster changeovers. Ideal for teams seeking flexible manufacturing models.

  7. Why Tailored CDMO Support Is A Non-Negotiable In Sterile Fill-Finish 4/13/2026

    Modern injectable programs require adaptable manufacturing strategies. Learn how flexibility, technical depth, and collaboration reduce complexity, manage change, and protect long‑term supply.

  8. Safely Scaling High Potency API Manufacturing 4/13/2026

    Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.

  9. Beyond Particle Counting: Why Modern Biologics Need Particle Forensics 4/8/2026

    High particle counts don’t always mean high risk. Identifying particle type and origin—not just quantity—avoids false alarms, protects timelines, and turns data into action.

  10. Optimize Time, Space and Cost With Inline Buffer Formulation And System 4/7/2026

    Discover how integrating inline buffer formulation with chromatography reduces buffer waste by 50% and delivers a 710% ROI, transforming downstream efficiency and sustainability.